​

Acrivon Therapeutics Ownership | Who Owns Acrivon Therapeutics?

OverviewForecastFinancialsChart

Acrivon Therapeutics Ownership Summary

Acrivon Therapeutics is owned by 61.01% institutional investors, 22.06% insiders, and 16.92% retail investors. HBM Healthcare Investments AG Ord is the top mutual fund, with 1.82% of its assets in Acrivon Therapeutics shares.

ACRV Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAcrivon Therapeutics61.01%22.06%16.92%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20245915.69%23,249,5511.26%611.68%3129.17%14-
Sep 30, 202451-22,960,755-2.09%601.43%24-31.43%14133.33%
Jun 30, 20245110.87%23,451,87853.83%641.43%3545.83%6-33.33%
Mar 31, 20244612.20%15,245,531-0.33%671.44%2433.33%9-
Dec 31, 202341-4.65%15,295,8761.34%681.47%18-5.26%9-25.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
HBM Healthcare Investments AG Ord566.65K1.82%-
Vanguard Total Stock Mkt Idx Inv409.46K1.31%1.97K
Vanguard US Total Market Shares ETF387.41K1.24%-
iShares Russell 2000 ETF287.40K0.92%-2.48K
Vanguard Institutional Extnd Mkt Idx Tr176.37K0.57%-
iShares Biotechnology ETF142.12K0.45%-1.58K
Fidelity Small Cap Index116.96K0.37%-2.19K
iShares Russell 2000 Value ETF111.10K0.35%-
Fidelity Extended Market Index74.33K0.24%-474.00
Bridgeway Ultra-Small Company Market73.00K0.23%-

Recent Insider Transactions

DateNameRoleActivityValue
Apr 11, 2024PERCEPTIVE ADVISORS LLC-Buy$20.00M
Jun 26, 2023Chione Ltd-Sell$206.88
Jun 15, 2023Chione Ltd-Sell$24.96K
Jun 12, 2023Chione Ltd-Sell$24.68K
Jun 13, 2023Chione Ltd-Sell$36.90K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q21-

ACRV Ownership FAQ

Who Owns Acrivon Therapeutics?

Acrivon Therapeutics shareholders are primarily institutional investors at 61.01%, followed by 22.06% insiders and 16.93% retail investors. The average institutional ownership in Acrivon Therapeutics's industry, Biotech Stocks , is 68.48%, which Acrivon Therapeutics falls below.

Does Blackrock own Acrivon Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Acrivon Therapeutics.

Who is the top mutual fund holder of Acrivon Therapeutics shares?

HBM Healthcare Investments AG Ord is the top mutual fund holder of Acrivon Therapeutics shares, with 1.82% of its total shares outstanding invested in 566.65K Acrivon Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools